FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2512229472> ?p ?o ?g. }

• W2512229472 endingPage "e548" @default.
• W2512229472 startingPage "e539" @default.
• W2512229472 abstract "Background In Africa, up to 30% of HIV-infected patients who are clinically eligible for antiretroviral therapy (ART) do not start timely treatment. We assessed the effects of an intervention targeting prevalent health systems barriers to ART initiation on timing and completeness of treatment initiation. Methods In this stepped-wedge, non-blinded, cluster-randomised controlled trial, 20 clinics in southwestern Uganda were randomly assigned in groups of five clinics every 6 months to the intervention by a computerised random number generator. This procedure continued until all clinics had crossed over from control (standard of care) to the intervention, which consisted of opinion-leader-led training and coaching of front-line health workers, a point-of-care CD4 cell count testing platform, a revised counselling approach without mandatory multiple pre-initiation sessions, and feedback to the facilities on their ART initiation rates and how they compared with other facilities. Treatment-naive, HIV-infected adults (aged ≥18 years) who were clinically eligible for ART during the study period were included in the study population. The primary outcome was ART initiation 14 days after first clinical eligibility for ART. This study is registered with ClinicalTrials.gov, number NCT01810289. Findings Between April 11, 2013, and Feb 2, 2015, 12 024 eligible patients visited one of the 20 participating clinics. Median CD4 count was 310 cells per μL (IQR 179–424). 3753 of 4747 patients (weighted proportion 80%) in the intervention group had started ART by 2 weeks after eligibility compared with 2585 of 7066 patients (38%) in the control group (risk difference 41·9%, 95% CI 40·1–43·8). Vital status was ascertained in a random sample of 208 patients in the intervention group and 199 patients in the control group. Four deaths (2%) occurred in the intervention group and five (3%) occurred in the control group. Interpretation A multicomponent intervention targeting health-care worker behaviour increased the probability of ART initiation 14 days after eligibility. This intervention consists of widely accessible components and has been tested in a real-world setting, and is therefore well positioned for use at scale. Funding National Institute of Allergy and Infectious Diseases (NIAID) and the President's Emergency Fund for AIDS Relief (PEPFAR)." @default.
• W2512229472 created "2016-09-16" @default.
• W2512229472 creator A5000997859 @default.
• W2512229472 creator A5019376012 @default.
• W2512229472 creator A5025305227 @default.
• W2512229472 creator A5038159516 @default.
• W2512229472 creator A5038528504 @default.
• W2512229472 creator A5052308665 @default.
• W2512229472 creator A5057401379 @default.
• W2512229472 creator A5067377269 @default.
• W2512229472 creator A5069551580 @default.
• W2512229472 creator A5076431226 @default.
• W2512229472 creator A5076966158 @default.
• W2512229472 creator A5083823135 @default.
• W2512229472 creator A5091174228 @default.
• W2512229472 creator A5091320270 @default.
• W2512229472 date "2016-11-01" @default.
• W2512229472 modified "2023-10-18" @default.
• W2512229472 title "Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial" @default.
• W2512229472 cites W1599007507 @default.
• W2512229472 cites W1964622370 @default.
• W2512229472 cites W1967548282 @default.
• W2512229472 cites W2008792371 @default.
• W2512229472 cites W2010050871 @default.
• W2512229472 cites W2016292497 @default.
• W2512229472 cites W2027736571 @default.
• W2512229472 cites W2032039690 @default.
• W2512229472 cites W2046609868 @default.
• W2512229472 cites W2048986863 @default.
• W2512229472 cites W2051878487 @default.
• W2512229472 cites W2055690472 @default.
• W2512229472 cites W2057708515 @default.
• W2512229472 cites W2069314911 @default.
• W2512229472 cites W2072428858 @default.
• W2512229472 cites W2073173905 @default.
• W2512229472 cites W2079766092 @default.
• W2512229472 cites W2112464708 @default.
• W2512229472 cites W2121262079 @default.
• W2512229472 cites W2122795395 @default.
• W2512229472 cites W2123717316 @default.
• W2512229472 cites W2130316654 @default.
• W2512229472 cites W2139939194 @default.
• W2512229472 cites W2144686010 @default.
• W2512229472 cites W2148958761 @default.
• W2512229472 cites W2155650815 @default.
• W2512229472 cites W2185153467 @default.
• W2512229472 cites W2363480212 @default.
• W2512229472 cites W2411527917 @default.
• W2512229472 cites W4254793567 @default.
• W2512229472 doi "https://doi.org/10.1016/s2352-3018(16)30090-x" @default.
• W2512229472 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5408866" @default.
• W2512229472 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27658873" @default.
• W2512229472 hasPublicationYear "2016" @default.
• W2512229472 type Work @default.
• W2512229472 sameAs 2512229472 @default.
• W2512229472 citedByCount "97" @default.
• W2512229472 countsByYear W25122294722016 @default.
• W2512229472 countsByYear W25122294722017 @default.
• W2512229472 countsByYear W25122294722018 @default.
• W2512229472 countsByYear W25122294722019 @default.
• W2512229472 countsByYear W25122294722020 @default.
• W2512229472 countsByYear W25122294722021 @default.
• W2512229472 countsByYear W25122294722022 @default.
• W2512229472 countsByYear W25122294722023 @default.
• W2512229472 crossrefType "journal-article" @default.
• W2512229472 hasAuthorship W2512229472A5000997859 @default.
• W2512229472 hasAuthorship W2512229472A5019376012 @default.
• W2512229472 hasAuthorship W2512229472A5025305227 @default.
• W2512229472 hasAuthorship W2512229472A5038159516 @default.
• W2512229472 hasAuthorship W2512229472A5038528504 @default.
• W2512229472 hasAuthorship W2512229472A5052308665 @default.
• W2512229472 hasAuthorship W2512229472A5057401379 @default.
• W2512229472 hasAuthorship W2512229472A5067377269 @default.
• W2512229472 hasAuthorship W2512229472A5069551580 @default.
• W2512229472 hasAuthorship W2512229472A5076431226 @default.
• W2512229472 hasAuthorship W2512229472A5076966158 @default.
• W2512229472 hasAuthorship W2512229472A5083823135 @default.
• W2512229472 hasAuthorship W2512229472A5091174228 @default.
• W2512229472 hasAuthorship W2512229472A5091320270 @default.
• W2512229472 hasBestOaLocation W25122294722 @default.
• W2512229472 hasConcept C126322002 @default.
• W2512229472 hasConcept C142462285 @default.
• W2512229472 hasConcept C159110408 @default.
• W2512229472 hasConcept C168563851 @default.
• W2512229472 hasConcept C176400912 @default.
• W2512229472 hasConcept C1862650 @default.
• W2512229472 hasConcept C187212893 @default.
• W2512229472 hasConcept C27415008 @default.
• W2512229472 hasConcept C2908647359 @default.
• W2512229472 hasConcept C2993143319 @default.
• W2512229472 hasConcept C3013748606 @default.
• W2512229472 hasConcept C512399662 @default.
• W2512229472 hasConcept C535046627 @default.
• W2512229472 hasConcept C71924100 @default.
• W2512229472 hasConcept C99454951 @default.
• W2512229472 hasConceptScore W2512229472C126322002 @default.
• W2512229472 hasConceptScore W2512229472C142462285 @default.
• W2512229472 hasConceptScore W2512229472C159110408 @default.

• next